PTC Therapeutics, Inc. ( PTCT) - Stock Earnings
PTCT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
PTCT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -135.0 million USD | 164.7 million USD |
| 2026Q1 | -2.8 million USD | 272.6 million USD |
| 2026Q2 | 83.5 million USD | 360.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PTCT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -626.6 million USD | 937.8 million USD |
| 2024 | -363.3 million USD | 806.8 million USD |
| 2025 | 682.6 million USD | 1.7 billion USD |
| 2026 Est. | — | — |
PTCT
Price: $60.99
52 week price:
Earnings Per Share: -0.67 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 588300
Ebitda: -20.6 millionMarket Capitalization: 5.3 billion